All Stories

  1. Recommendations for reporting findings from analyses using artificial intelligence and machine learning in the Journal of Alzheimer's Disease
  2. Alzheimer’s disease: diabetes of the brain
  3. Lipid droplet dysmetabolism affects cell homeostasis in an in vitro model of Alzheimer’s disease
  4. Therapeutic Trials in Alzheimer’s Disease: Where Are We Now?
  5. Fueling Alzheimer’s Disease: Where Does Immunometabolism Stand?
  6. MitoTempo protects against nε-carboxymethyl lysine-induced mitochondrial dyshomeostasis and neuronal cells injury
  7. Protective effects of 2,4-dinitrophenol in okadaic acid-induced cellular model of Alzheimer's disease
  8. Corrigendum: Normative mice retinal thickness: 16-month longitudinal characterization of wild-type mice and changes in a model of Alzheimer's disease
  9. Mapping the lipidome in mitochondria‐associated membranes (MAMs) in an in vitro model of Alzheimer's disease
  10. Neuro–glia communication and glycolysis
  11. Current Advances in Mitochondrial Targeted Interventions in Alzheimer’s Disease
  12. Therapeutic potential of glutaminyl cyclases: Current status and emerging trends
  13. Normative mice retinal thickness: 16-month longitudinal characterization of wild-type mice and changes in a model of Alzheimer's disease
  14. Retinal imaging in animal models: Searching for biomarkers of neurodegeneration
  15. Metabolic defects shared by Alzheimer's disease and diabetes: A focus on mitochondria
  16. A Perspective on the Link between Mitochondria-Associated Membranes (MAMs) and Lipid Droplets Metabolism in Neurodegenerative Diseases
  17. Disrupted cellular quality control mechanisms in aging
  18. Longitudinal OCT texture analysis to assess the retinal changes in the triple‐transgenic mouse model of Alzheimer's disease
  19. WWOX inhibition by Zfra1-31 restores mitochondrial homeostasis and viability of neuronal cells exposed to high glucose
  20. Stage-independent biomarkers for Alzheimer’s disease from the living retina: an animal study
  21. Type 2 Diabetes Induces a Pro-Oxidative Environment in Rat Epididymis by Disrupting SIRT1/PGC-1α/SIRT3 Pathway
  22. Retinal Aging in 3× Tg-AD Mice Model of Alzheimer's Disease
  23. Hypoxic Preconditioning Averts Sporadic Alzheimer's Disease-Like Phenotype in Rats: A Focus on Mitochondria
  24. ER-mitochondria communication is involved in NLRP3 inflammasome activation under stress conditions in the innate immune system
  25. Insulin-Induced Recurrent Hypoglycemia Up-Regulates Glucose Metabolism in the Brain Cortex of Chemically Induced Diabetic Rats
  26. Targeting Mitochondria and Redox Dyshomeostasis in Brain Ageing: An Update
  27. Oxygen Sensing and Signaling in Alzheimer’s Disease: A Breathtaking Story!
  28. Structural and Functional Alterations in Mitochondria-Associated Membranes (MAMs) and in Mitochondria Activate Stress Response Mechanisms in an In Vitro Model of Alzheimer’s Disease
  29. Longitudinal normative OCT retinal thickness data for wild-type mice, and characterization of changes in the 3×Tg-AD mice model of Alzheimer's disease
  30. WWOX: A New Therapeutic Target In Type 2 Diabetes-Associated Neurodegeneration
  31. Retina and Brain Display Early and Differential Molecular and Cellular Changes in the 3xTg-AD Mouse Model of Alzheimer’s Disease
  32. IGF1R Deficiency Modulates Brain Signaling Pathways and Disturbs Mitochondria and Redox Homeostasis
  33. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer’s Disease
  34. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
  35. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation
  36. Associations between Trace Elements and Cognitive Decline: An Exploratory 5-Year Follow-Up Study of an Elderly Cohort
  37. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
  38. Mitochondria, endoplasmic reticulum and innate immune dysfunction in mood disorders: Do Mitochondria-Associated Membranes (MAMs) play a role?
  39. Characterization of the retinal changes of the 3×Tg-AD mouse model of Alzheimer’s disease
  40. Combining Virtual Screening Protocol and In Vitro Evaluation towards the Discovery of BACE1 Inhibitors
  41. Liraglutide Protects Against Brain Amyloid-β1–42 Accumulation in Female Mice with Early Alzheimer’s Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation
  42. The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington's disease mice
  43. Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones
  44. Cognitive Impairment in Obesity and Diabetes
  45. An overview of glutaminyl cyclase inhibitors for Alzheimer’s disease
  46. Retinal thickness of the triple‐transgenic mice model of Alzheimer\’s disease at the age of one month
  47. Is Alzheimer’s disease an inflammasomopathy?
  48. Links between Cognitive Status and Trace Element Levels in Hair for an Environmentally Exposed Population: A Case Study in the Surroundings of the Estarreja Industrial Area
  49. Retinal thinning of inner sub-layers is associated with cortical atrophy in a mouse model of Alzheimer’s disease: a longitudinal multimodal in vivo study
  50. Characterization of the Retinal Changes of the 3xTg-AD Mouse Model of Alzheimer’s Disease
  51. Post-translational modifications in brain health and disease
  52. Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies
  53. Diabesity and brain disturbances: A metabolic perspective
  54. A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss
  55. The Retina as a Window or Mirror of the Brain Changes Detected in Alzheimer’s Disease: Critical Aspects to Unravel
  56. Tortuous Paths of Insulin Signaling and Mitochondria in Alzheimer’s Disease
  57. Can the retina show similar molecular and cellular changes as the brain in an animal model of Alzheimer’s disease?
  58. O-GlcNAcylation and neuronal energy status: Implications for Alzheimer’s disease
  59. Oxidative Stress: A Major Player in Cerebrovascular Alterations Associated to Neurodegenerative Events
  60. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease
  61. Preface
  62. Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington’s Disease
  63. Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
  64. Beneficial effects of white wine polyphenols-enriched diet on Alzheimer’s disease-like pathology
  65. The beneficial role of exercise in mitigating doxorubicin-induced Mitochondrionopathy
  66. Sweet Mitochondria: A Shortcut to Alzheimer’s Disease
  67. Fingernail Trace Element Content in Environmentally Exposed Individuals and Its Influence on Their Cognitive Status in Ageing
  68. Uncoupling Protein 2 Inhibition Exacerbates Glucose Fluctuation-Mediated Neuronal Effects
  69. Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats
  70. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid
  71. Human predisposition to cognitive impairment and its relation with environmental exposure to potentially toxic elements
  72. Diabesity and Brain Energy Metabolism: The Case of Alzheimer’s Disease
  73. Mitochondria in Alzheimer’s Disease and Diabetes-Associated Neurodegeneration: License to Heal!
  74. Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology
  75. Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology
  76. Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks
  77. Mini-Symposium: Energy Demand and Energy Supply in Alzheimer's Disease - Introduction
  78. Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine
  79. Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease
  80. UMIB Summit 2015
  81. Erratum
  82. Phosphatase 2A Inhibition Affects Endoplasmic Reticulum and Mitochondria Homeostasis Via Cytoskeletal Alterations in Brain Endothelial Cells
  83. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
  84. Physical exercise mitigates doxorubicin-induced brain cortex and cerebellum mitochondrial alterations and cellular quality control signaling
  85. Tackling Alzheimer’s Disease by Targeting Oxidative Stress and Mitochondria
  86. White tea (Camellia sinensis) consumption improves heart and brain glycolytic and oxidative profiles in prediabetic rats
  87. Kaurane diterpenes as mitochondrial alterations preventive agents under experimental oxidative stress conditions
  88. Testosterone deficiency induced by progressive stages of diabetes mellitus impairs glucose metabolism and favors glycogenesis in mature rat Sertoli cells
  89. Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers
  90. Physical exercise improves brain cortex and cerebellum mitochondrial bioenergetics and alters apoptotic, dynamic and auto(mito)phagy markers
  91. The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases
  92. Metabolic fingerprints in testicular biopsies from type 1 diabetic patients
  93. Abstract book of the 31stESHRE Annual Meeting, Lisbon, Portugal, 14–17 June 2015
  94. Endoplasmic reticulum stress
  95. Alzheimer's Disease-Related Misfolded Proteins and Dysfunctional Organelles on Autophagy Menu
  96. Type 2 Diabetes Aggravates Alzheimer's Disease-Associated Vascular Alterations of the Aorta in Mice
  97. Daily consumption of white tea (Camellia sinensis (L.)) improves the cerebral cortex metabolic and oxidative profile in prediabetic Wistar rats
  98. Exercise-Induced Protection Against Aging and Neurodegenerative Diseases
  99. Cerebrovascular and mitochondrial abnormalities in Alzheimer’s disease: a brief overview
  100. Autophagy in Alzheimer’s disease: A Cleaning Service Out-of-order?
  101. Cardiolipin Profile Changes are Associated to the Early Synaptic Mitochondrial Dysfunction in Alzheimer's Disease
  102. Vascular, Oxidative, and Synaptosomal Abnormalities During Aging and the Progression of Type 2 Diabetes
  103. Perspectives on mitochondrial uncoupling proteins-mediated neuroprotection
  104. The role of endoplasmic reticulum in amyloid precursor protein processing and trafficking: Implications for Alzheimer's disease
  105. Enhanced Amyloidogenic Processing of Amyloid Precursor Protein and Cell Death Under Prolonged Endoplasmic Reticulum Stress in Brain Endothelial Cells
  106. Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease – How Anti-Diabetics Could be a Solution for Dementia
  107. Insulin therapy modulates mitochondrial dynamics and biogenesis, autophagy and tau protein phosphorylation in the brain of type 1 diabetic rats
  108. Effects of methylglyoxal and pyridoxamine in rat brain mitochondria bioenergetics and oxidative status
  109. Amyloid-Beta Disrupts Calcium and Redox Homeostasis in Brain Endothelial Cells
  110. Mitochondrial quality control systems sustain brain mitochondrial bioenergetics in early stages of type 2 diabetes
  111. Androgens regulate gene expression of glucose transporters and glycolytic enzymes in prostate cancer cells
  112. Pre-diabetes alters testicular PGC1-α/SIRT3 axis modulating mitochondrial bioenergetics and oxidative stress
  113. Role of Mitochondria and Oxidative Stress in Parkinson’s Disease
  114. Metformin and male reproduction: effects on Sertoli cell metabolism
  115. Alzheimer's Disease: An Overview☆
  116. Alzheimer's Disease
  117. Increased Susceptibility to Amyloid-β Toxicity in Rat Brain Microvascular Endothelial Cells under Hyperglycemic Conditions
  118. The Janus Face of Insulin in Brain
  119. Is exercise-in-a-bottle likely to proffer new insights into Alzheimer's disease?
  120. Control of Sertoli cell metabolism by sex steroid hormones is mediated through modulation in glycolysis-related transporters and enzymes
  121. Exposure to 2,4-dichlorophenoxyacetic acid alters glucose metabolism in immature rat Sertoli cells
  122. High-sugar diets, type 2 diabetes and Alzheimerʼs disease
  123. Author Index
  124. Mitochondrial DNA Oxidative Damage and Repair in Aging and Alzheimer's Disease
  125. Session 01: Keynote lectures session
  126. Mitochondrial-Targeted Protective Properties of Isolated Diterpenoids fromSideritisspp. in Response to the Deleterious Changes Induced by H2O2
  127. Neurofilaments are the major neuronal target of hydroxynonenal-mediated protein cross-links
  128. Type 2 Diabetic and Alzheimer's Disease Mice Present Similar Behavioral, Cognitive, and Vascular Anomalies
  129. Molecular mechanisms beyond glucose transport in diabetes-related male infertility
  130. Hyperglycemia, Hypoglycemia and Dementia: Role of Mitochondria and Uncoupling Proteins
  131. Mitochondrial Abnormalities in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease
  132. Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration
  133. UCP2 and ANT differently modulate proton-leak in brain mitochondria of long-term hyperglycemic and recurrent hypoglycemic rats
  134. Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer’s Disease
  135. Insulin-induced recurrent hypoglycemia exacerbates diabetic brain mitochondrial dysfunction and oxidative imbalance
  136. Mechanism of inhibition of mitochondrial ATP synthase by 17β−Estradiol
  137. The impairment of insulin signaling in Alzheimer's disease
  138. Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile
  139. Alzheimer disease as a vascular disorder: Where do mitochondria fit?
  140. Physical exercise as a possible strategy for brain protection: Evidence from mitochondrial-mediated mechanisms
  141. Impact of Diabetes in Blood-Testis and Blood-Brain Barriers: Resemblances and Differences
  142. Hormonal control of Sertoli cell metabolism regulates spermatogenesis
  143. Alzheimer's Disease and Diabetes: An Integrative View of the Role of Mitochondria, Oxidative Stress, and Insulin
  144. Oxidative Damage to RNA in Aging and Neurodegenerative Disorders
  145. Guidelines for the use and interpretation of assays for monitoring autophagy
  146. Association of Mitochondrial Signaling in Alzheimer’s Disease and Hypoxia
  147. Metabolic Alterations Induced by Sucrose Intake and Alzheimer’s Disease Promote Similar Brain Mitochondrial Abnormalities
  148. The role of iron as a mediator of oxidative stress in Alzheimer disease
  149. Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation
  150. Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover
  151. Nuclear and mitochondrial DNA oxidation in Alzheimer's disease
  152. Mitochondrial Importance in Alzheimer’s, Huntington’s and Parkinson’s Diseases
  153. Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?
  154. Cyanide preconditioning protects brain endothelial and NT2 neuron-like cells against glucotoxicity: Role of mitochondrial reactive oxygen species and HIF-1α
  155. Insulin in Central Nervous System: More than Just a Peripheral Hormone
  156. New Insights into the Mechanisms of Mitochondrial Preconditioning-Triggered Neuroprotection
  157. Oxidative Stress and Balance in Neurodegenerative Diseases
  158. Neurofilamentopathy in Neurodegenerative Diseases
  159. Mitophagy in Neurodegeneration: An Opportunity for Therapy?
  160. Effects of rapamycin and TOR on aging and memory: implications for Alzheimer’s disease
  161. Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?
  162. SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
  163. Mitochondria as Potential Targets in Antidiabetic Therapy
  164. Mitochondria from distinct tissues are differently affected by 17β-estradiol and tamoxifen
  165. Cortical and hippocampal mitochondria bioenergetics and oxidative status during hyperglycemia and/or insulin-induced hypoglycemia
  166. Impact of STZ-induced hyperglycemia and insulin-induced hypoglycemia in plasma amino acids and cortical synaptosomal neurotransmitters
  167. Autophagy in Alzheimer’s disease
  168. Effects of Estrogen in the Brain: Is it a Neuroprotective Agent in Alzheimers Disease?
  169. A Synergistic Dysfunction of Mitochondrial Fission/Fusion Dynamics and Mitophagy in Alzheimer's Disease
  170. Mitochondria: The Missing Link Between Preconditioning and Neuroprotection
  171. Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease
  172. Mitochondrial preconditioning: a potential neuroprotective strategy
  173. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
  174. Mitochondria: A therapeutic target in neurodegeneration
  175. Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration?
  176. Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
  177. Natural Oxidant Balance in Parkinson Disease
  178. Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes
  179. Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia
  180. Doxorubicin: The Good, the Bad and the Ugly Effect
  181. An Integrative View of the Role of Oxidative Stress, Mitochondria and Insulin in Alzheimer's Disease
  182. RNA oxidation in Alzheimer disease and related neurodegenerative disorders
  183. Altered redox balance in disease: Can we change the new equilibria?
  184. Alzheimer’s Disease: An Overview
  185. Neurofibrillary Tangle Formation as a Protective Response to Oxidative Stress in Alzheimer’s Disease
  186. Alzheimer Disease: Oxidative Stress and Compensatory Responses
  187. Food Deprivation Promotes Oxidative Imbalance in Rat Brain
  188. Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins
  189. Oxidative Stress Signaling in Alzheimers Disease
  190. Mechanisms of Action of Metformin in Type 2 Diabetes and Associated Complications: An Overview
  191. Antioxidant Therapy in Alzheimers Disease: Theory and Practice
  192. Doxorubicin increases the susceptibility of brain mitochondria to Ca2+-induced permeability transition and oxidative damage
  193. Metformin Protects the Brain Against the Oxidative Imbalance Promoted by Type 2 Diabetes
  194. P4‐183: Increased oxidative stress is an early pathological feature in 3xTg‐AD mice
  195. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease
  196. Sublethal RNA Oxidation as a Mechanism for Neurodegenerative Disease
  197. Nucleic acid oxidation in Alzheimer disease
  198. Alzheimer Disease and the Role of Free Radicals in the Pathogenesis of the Disease
  199. Neuronal Death and Survival Under Oxidative Stress in Alzheimer and Parkinson Diseases
  200. Oxidative RNA Damage and Neurodegeneration
  201. Metformin promotes isolated rat liver mitochondria impairment
  202. Alzheimer's Disease: A Lesson from Mitochondrial Dysfunction
  203. Soybean oil treatment impairs glucose-stimulated insulin secretion and changes fatty acid composition of normal and diabetic islets
  204. Errata
  205. Autophagocytosis of Mitochondria Is Prominent in Alzheimer Disease
  206. Vascular oxidative stress in Alzheimer disease
  207. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes
  208. Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease
  209. Estradiol affects liver mitochondrial function in ovariectomized and tamoxifen-treated ovariectomized female rats
  210. Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?
  211. Indices of Metabolic Dysfunction and Oxidative Stress
  212. Prevention and Treatment of Alzheimer Disease and Aging: Antioxidants
  213. The Potential Application of Antioxidant Agents in Alzheimer Disease Therapeutics
  214. The Key Role of Oxidative Stress in Alzheimer's Disease
  215. Foreword: Mitochondria in Alzheimer disease
  216. Involvement of Oxidative Stress in Alzheimer Disease
  217. Telomeres and telomerase in Alzheimer’s disease: Epiphenomena or a new focus for therapeutic strategy?
  218. Therapeutic options in Alzheimer’s disease
  219. The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease
  220. Neuropathology in Alzheimer's Disease: Awaking from a Hundred-Year-Old Dream
  221. Insulin Attenuates Diabetes-Related Mitochondrial Alterations: A Comparative Study
  222. Presenilin mutation: A deadly first hit in Alzheimer disease
  223. Tamoxifen and Estradiol Interact with the Flavin Mononucleotide Site of Complex I Leading to Mitochondrial Failure
  224. Compensatory responses induced by oxidative stress in Alzheimer disease
  225. CoQ10 therapy attenuates amyloid β-peptide toxicity in brain mitochondria isolated from aged diabetic rats
  226. Oxidative Stress: The Old Enemy in Alzheimers Disease Pathophysiology
  227. Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease
  228. Alzheimer's disease: an intracellular movement disorder?
  229. Redox metals and oxidative abnormalities in human prion diseases
  230. Alzheimers Disease-Associated Neurotoxic Mechanisms and Neuroprotective Strategies
  231. Neurodegenerative Pathways in Parkinsons Disease: Therapeutic Strategies
  232. Oxidative Stress and Neurodegeneration
  233. Therapeutic Opportunities in Alzheimer Disease: One for all or all for One?
  234. Chronological primacy of oxidative stress in Alzheimer disease
  235. Tau phosphorylation in Alzheimer's disease: pathogen or protector?
  236. A Second Look into the Oxidant Mechanisms in Alzheimers Disease
  237. Insulin protects against amyloid β-peptide toxicity in brain mitochondria of diabetic rats
  238. Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron
  239. Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations
  240. Brain mitochondrial injury induced by oxidative stress-related events is prevented by tamoxifen
  241. Mitogen- and stress-activated protein kinase 1: Convergence of the ERK and p38 pathways in Alzheimer's disease
  242. Biphasic expression of lipin suggests dual roles in adipocyte development
  243. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease
  244. Neurofilament proteins in neurodegenerative diseases
  245. Therapeutic potential of oxidant mechanisms in Alzheimer’s disease
  246. Hydroxytamoxifen protects against oxidative stress in brain mitochondria
  247. Effect of Streptozotocin-Induced Diabetes on Rat Brain Mitochondria
  248. Effect of Streptozotocin‐Induced Diabetes on Rat Brain Mitochondria
  249. Increased Vulnerability of Brain Mitochondria in Diabetic (Goto-Kakizaki) Rats With Aging and Amyloid-  Exposure
  250. Effect of amyloid ?-peptide on permeability transition pore: A comparative study
  251. Amyloid β-Peptide Promotes Permeability Transition Pore in Brain Mitochondria
  252. Effect of Zinc Ions on the Cytotoxicity Induced by the Amyloid β-Peptide
  253. Susceptibility to β-Amyloid-Induced Toxicity Is Decreased in Goto-Kakizaki Diabetic Rats: Involvement of Oxidative Stress